Single Use Gene Therapy Approved in the EU for Leber’s Congenital Amaurosis
<a href="https://pixabay.com/users/Free-Photos/">Free-Photos</a> / Pixabay

Single Use Gene Therapy Approved in the EU for Leber’s Congenital Amaurosis

According to a story from pm360online.com, the drug developer Novartis has recently announced that the company's gene therapy Luxturna has gained approval in the EU as a treatment for Leber's…

Continue Reading
Close Menu